This blog summarizes research trends based on published paper abstracts. Specific numbers or findings may contain inaccuracies. For scholarly rigor, always consult the original papers cited in each post.
The racial disparity in cancer outcomes in the United States is well documented: Black women are more likely to die from breast cancer than white women despite similar incidence rates. Black men have higher lung cancer incidence and mortality than white men across most age groups. These disparities have persisted—and in some cases widened—despite decades of improvements in screening, treatment, and access to care.
The sociological question is not whether these disparities exist but why they persist. Individual-level explanations—genetics, health behaviors, access to insurance—account for a portion of the gap but leave substantial unexplained variance. A growing body of epidemiological and sociological research points to a structural explanation: racial disparities in cancer outcomes are, to a significant degree, produced by the places where people live, and the places where people live are shaped by decades of racist housing policy, educational segregation, and economic disinvestment.
Measuring Structural Racism
Shariff-Marco, Guan, and Lin (2025) address a methodological challenge that has limited structural racism research: how to measure a phenomenon that operates across multiple institutional domains simultaneously. Structural racism, as they define it, manifests through systems of mutually reinforcing institutions that perpetuate inequities through policies, practices, and norms across domains including housing, education, employment, criminal justice, and healthcare.
Their contribution is the development of racial and ethnic-specific composite measures of structural racism using data from the Multiethnic Cohort Study. Rather than using a single indicator (such as residential segregation or income inequality), the composite measure integrates multiple dimensions—contemporary redlining, residential segregation, education, employment, incarceration, fatal encounters with police, and home rentership—into a single measure calibrated for specific racial and ethnic groups.
The specificity is important. Structural racism does not operate identically across all minoritized groups. The mechanisms that disadvantage Black Americans (historical redlining, mass incarceration, educational segregation) differ from those that disadvantage Latino Americans (immigration enforcement, language barriers, occupational segregation) or Asian Americans (model minority stereotyping, disaggregation challenges). A measure that treats "structural racism" as a monolithic construct misses these differences.
Breast Cancer: From Diagnosis to Death
Falcone, Salhia, and Hughes Halbert (2024) examine the pathways by which structural racism contributes to breast cancer mortality disparities. The striking ethnic and racial disparities in breast cancer mortality, they note, are not explained fully by pathological or clinical features. Structural racism contributes to adverse conditions that promote cancer inequities, but the pathways by which this occurs are not fully understood.
The paper identifies several mediating mechanisms through which neighborhood-level structural racism translates into individual-level cancer outcomes:
- Environmental exposures: Neighborhoods shaped by redlining are disproportionately located near industrial facilities, highways, and toxic waste sites, producing higher exposure to carcinogens and endocrine disruptors.
- Healthcare access: Structurally disadvantaged neighborhoods have fewer oncology specialists, longer travel times to treatment centers, and fewer clinical trial sites—reducing the quality and timeliness of cancer care.
- Chronic stress: The psychosocial burden of living in structurally disadvantaged environments—poverty, violence, discrimination, environmental degradation—produces chronic stress that affects immune function, inflammation, and tumor biology through established neuroendocrine pathways.
Treatment Delay: Where Structural Racism Meets Clinical Outcomes
Reeder-Hayes, Jackson, and Kuo (2024) provide one of the most methodologically rigorous studies linking structural racism to a specific clinical outcome: treatment delay in breast cancer. The study develops a multidimensional county-level structural racism measure and examines its association with time from diagnosis to treatment initiation among Black and white breast cancer patients.
Treatment delay matters clinically because breast cancer that is diagnosed at an early stage but treated late may progress, reducing the survival advantage that early detection provides. If structural racism produces treatment delay, then the benefits of screening programs are partially negated for populations living in structurally disadvantaged areas—a finding with direct policy implications for cancer control strategies.
The county-level approach is significant because it captures the geographic concentration of structural disadvantage: counties with high structural racism scores cluster in the Deep South, Appalachian region, and deindustrialized Midwest—regions where both Black populations and health system deficiencies are concentrated. The spatial overlap between structural racism and healthcare infrastructure gaps creates a compounding effect that individual-level interventions cannot address.
Beyond Cancer: Structural Racism and Maternal Health
Janevic, Howell, and Burdick (2025) extend the structural racism framework to postpartum hypertension—a condition that is a key factor in racial-ethnic inequities in maternal mortality. The study examines associations between gendered racial microaggressions during pregnancy and labor and postpartum blood pressure in a multiethnic prospective cohort.
This paper bridges the structural and interpersonal dimensions of racism. Structural racism creates the conditions—segregated neighborhoods, under-resourced hospitals, biased clinical encounters—within which interpersonal racism (microaggressions, discriminatory treatment, dismissal of symptoms) occurs. The physiological consequences of these combined exposures include chronic hypertension, postpartum preeclampsia, and cardiovascular complications that contribute to the maternal mortality crisis among Black women in the US.
Lung Cancer: Neighborhood Disinvestment and Incidence
Sangaramoorthy, Lin, and Zhou (2025) investigate associations of structural racism and neighborhood disinvestment with lung cancer risk, using two large prospective cohorts. Despite declining incidence rates of lung cancer in the US, racial/ethnic disparities persist, highlighting the need to examine structural and social drivers beyond individual-level risk factors like smoking.
The study's focus on neighborhood disinvestment—the withdrawal of public and private investment from specific geographic areas—provides a concrete, policy-relevant mechanism linking structural racism to cancer risk. Disinvested neighborhoods have higher concentrations of air pollution, fewer green spaces, more tobacco retail outlets, and less access to smoking cessation services—all of which contribute to lung cancer risk through pathways that are structurally determined rather than individually chosen.
Claims and Evidence
<
| Claim | Evidence | Verdict |
|---|
| Structural racism is a fundamental cause of cancer disparities | Falcone et al. (2024), Reeder-Hayes et al. (2024): multidimensional evidence across breast cancer outcomes | ✅ Supported |
| Neighborhood-level structural racism affects treatment timeliness | Reeder-Hayes et al. (2024): county-level SR measure associated with treatment delay | ✅ Supported |
| Structural racism operates through both material and psychosocial pathways | Falcone et al. (2024): environmental exposure, healthcare access, and chronic stress identified | ✅ Supported |
| Structural racism measures should be race/ethnicity-specific | Shariff-Marco et al. (2025): different mechanisms operate for different groups | ✅ Supported |
| Individual-level interventions can address structurally produced health disparities | No study supports this; all point to structural interventions | ❌ Refuted |
Open Questions
Can structural racism measures be used prospectively for health planning? If county-level structural racism scores predict cancer outcomes, can they be used to target healthcare infrastructure investment, cancer screening programs, and clinical trial placement?How does structural racism interact with the healthcare system at the point of care? The research reviewed here documents neighborhood-level effects but does not fully disentangle them from within-system discrimination (provider bias, insurance coverage gaps, algorithmic triage tools).What structural interventions would reduce cancer disparities? The logical implication of the structural racism framework is that health interventions must be structural—housing policy, educational investment, environmental regulation, economic development. What evidence exists for the health effects of these upstream interventions?How do these dynamics operate outside the US? The research is overwhelmingly US-based. Do analogous structural mechanisms produce health disparities in other racially stratified societies (Brazil, South Africa, the UK)?Implications
The research reviewed here demands a reorientation in how we think about cancer disparities—and health disparities more broadly. If the fundamental drivers of racial disparities in cancer outcomes are structural (housing, education, employment, environment), then the fundamental solutions must be structural as well. Clinical interventions—better screening, better treatment, better access—are necessary but insufficient. They address the downstream consequences of structural disadvantage without addressing the upstream causes.
For health researchers, this means that cancer epidemiology must incorporate structural measures as exposures, not merely as confounders to be controlled away. For policymakers, it means that health equity cannot be achieved through healthcare policy alone—it requires coordinated action across housing, education, employment, environmental, and criminal justice policy domains. For communities, it means that health advocacy must be connected to structural change advocacy—because the zip code a person lives in predicts their cancer outcomes more reliably than most clinical risk factors.
The racial disparity in cancer outcomes in the United States is well documented: Black women are more likely to die from breast cancer than white women despite similar incidence rates. Black men have higher lung cancer incidence and mortality than white men across most age groups. These disparities have persisted—and in some cases widened—despite decades of improvements in screening, treatment, and access to care.
The sociological question is not whether these disparities exist but why they persist. Individual-level explanations—genetics, health behaviors, access to insurance—account for a portion of the gap but leave substantial unexplained variance. A growing body of epidemiological and sociological research points to a structural explanation: racial disparities in cancer outcomes are, to a significant degree, produced by the places where people live, and the places where people live are shaped by decades of racist housing policy, educational segregation, and economic disinvestment.
Measuring Structural Racism
Shariff-Marco, Guan, and Lin (2025) address a methodological challenge that has limited structural racism research: how to measure a phenomenon that operates across multiple institutional domains simultaneously. Structural racism, as they define it, manifests through systems of mutually reinforcing institutions that perpetuate inequities through policies, practices, and norms across domains including housing, education, employment, criminal justice, and healthcare.
Their contribution is the development of racial and ethnic-specific composite measures of structural racism using data from the Multiethnic Cohort Study. Rather than using a single indicator (such as residential segregation or income inequality), the composite measure integrates multiple dimensions—contemporary redlining, residential segregation, education, employment, incarceration, fatal encounters with police, and home rentership—into a single measure calibrated for specific racial and ethnic groups.
The specificity is important. Structural racism does not operate identically across all minoritized groups. The mechanisms that disadvantage Black Americans (historical redlining, mass incarceration, educational segregation) differ from those that disadvantage Latino Americans (immigration enforcement, language barriers, occupational segregation) or Asian Americans (model minority stereotyping, disaggregation challenges). A measure that treats "structural racism" as a monolithic construct misses these differences.
Breast Cancer: From Diagnosis to Death
Falcone, Salhia, and Hughes Halbert (2024) examine the pathways by which structural racism contributes to breast cancer mortality disparities. The striking ethnic and racial disparities in breast cancer mortality, they note, are not explained fully by pathological or clinical features. Structural racism contributes to adverse conditions that promote cancer inequities, but the pathways by which this occurs are not fully understood.
The paper identifies several mediating mechanisms through which neighborhood-level structural racism translates into individual-level cancer outcomes:
- Environmental exposures: Neighborhoods shaped by redlining are disproportionately located near industrial facilities, highways, and toxic waste sites, producing higher exposure to carcinogens and endocrine disruptors.
- Healthcare access: Structurally disadvantaged neighborhoods have fewer oncology specialists, longer travel times to treatment centers, and fewer clinical trial sites—reducing the quality and timeliness of cancer care.
- Chronic stress: The psychosocial burden of living in structurally disadvantaged environments—poverty, violence, discrimination, environmental degradation—produces chronic stress that affects immune function, inflammation, and tumor biology through established neuroendocrine pathways.
Treatment Delay: Where Structural Racism Meets Clinical Outcomes
Reeder-Hayes, Jackson, and Kuo (2024) provide one of the most methodologically rigorous studies linking structural racism to a specific clinical outcome: treatment delay in breast cancer. The study develops a multidimensional county-level structural racism measure and examines its association with time from diagnosis to treatment initiation among Black and white breast cancer patients.
Treatment delay matters clinically because breast cancer that is diagnosed at an early stage but treated late may progress, reducing the survival advantage that early detection provides. If structural racism produces treatment delay, then the benefits of screening programs are partially negated for populations living in structurally disadvantaged areas—a finding with direct policy implications for cancer control strategies.
The county-level approach is significant because it captures the geographic concentration of structural disadvantage: counties with high structural racism scores cluster in the Deep South, Appalachian region, and deindustrialized Midwest—regions where both Black populations and health system deficiencies are concentrated. The spatial overlap between structural racism and healthcare infrastructure gaps creates a compounding effect that individual-level interventions cannot address.
Beyond Cancer: Structural Racism and Maternal Health
Janevic, Howell, and Burdick (2025) extend the structural racism framework to postpartum hypertension—a condition that is a key factor in racial-ethnic inequities in maternal mortality. The study examines associations between gendered racial microaggressions during pregnancy and labor and postpartum blood pressure in a multiethnic prospective cohort.
This paper bridges the structural and interpersonal dimensions of racism. Structural racism creates the conditions—segregated neighborhoods, under-resourced hospitals, biased clinical encounters—within which interpersonal racism (microaggressions, discriminatory treatment, dismissal of symptoms) occurs. The physiological consequences of these combined exposures include chronic hypertension, postpartum preeclampsia, and cardiovascular complications that contribute to the maternal mortality crisis among Black women in the US.
Lung Cancer: Neighborhood Disinvestment and Incidence
Sangaramoorthy, Lin, and Zhou (2025) investigate associations of structural racism and neighborhood disinvestment with lung cancer risk, using two large prospective cohorts. Despite declining incidence rates of lung cancer in the US, racial/ethnic disparities persist, highlighting the need to examine structural and social drivers beyond individual-level risk factors like smoking.
The study's focus on neighborhood disinvestment—the withdrawal of public and private investment from specific geographic areas—provides a concrete, policy-relevant mechanism linking structural racism to cancer risk. Disinvested neighborhoods have higher concentrations of air pollution, fewer green spaces, more tobacco retail outlets, and less access to smoking cessation services—all of which contribute to lung cancer risk through pathways that are structurally determined rather than individually chosen.
Claims and Evidence
<
| Claim | Evidence | Verdict |
|---|
| Structural racism is a fundamental cause of cancer disparities | Falcone et al. (2024), Reeder-Hayes et al. (2024): multidimensional evidence across breast cancer outcomes | ✅ Supported |
| Neighborhood-level structural racism affects treatment timeliness | Reeder-Hayes et al. (2024): county-level SR measure associated with treatment delay | ✅ Supported |
| Structural racism operates through both material and psychosocial pathways | Falcone et al. (2024): environmental exposure, healthcare access, and chronic stress identified | ✅ Supported |
| Structural racism measures should be race/ethnicity-specific | Shariff-Marco et al. (2025): different mechanisms operate for different groups | ✅ Supported |
| Individual-level interventions can address structurally produced health disparities | No study supports this; all point to structural interventions | ❌ Refuted |
Open Questions
Can structural racism measures be used prospectively for health planning? If county-level structural racism scores predict cancer outcomes, can they be used to target healthcare infrastructure investment, cancer screening programs, and clinical trial placement?How does structural racism interact with the healthcare system at the point of care? The research reviewed here documents neighborhood-level effects but does not fully disentangle them from within-system discrimination (provider bias, insurance coverage gaps, algorithmic triage tools).What structural interventions would reduce cancer disparities? The logical implication of the structural racism framework is that health interventions must be structural—housing policy, educational investment, environmental regulation, economic development. What evidence exists for the health effects of these upstream interventions?How do these dynamics operate outside the US? The research is overwhelmingly US-based. Do analogous structural mechanisms produce health disparities in other racially stratified societies (Brazil, South Africa, the UK)?Implications
The research reviewed here demands a reorientation in how we think about cancer disparities—and health disparities more broadly. If the fundamental drivers of racial disparities in cancer outcomes are structural (housing, education, employment, environment), then the fundamental solutions must be structural as well. Clinical interventions—better screening, better treatment, better access—are necessary but insufficient. They address the downstream consequences of structural disadvantage without addressing the upstream causes.
For health researchers, this means that cancer epidemiology must incorporate structural measures as exposures, not merely as confounders to be controlled away. For policymakers, it means that health equity cannot be achieved through healthcare policy alone—it requires coordinated action across housing, education, employment, environmental, and criminal justice policy domains. For communities, it means that health advocacy must be connected to structural change advocacy—because the zip code a person lives in predicts their cancer outcomes more reliably than most clinical risk factors.
References (5)
[1] Falcone, M., Salhia, B., & Hughes Halbert, C. (2024). Impact of Structural Racism and Social Determinants of Health on Disparities in Breast Cancer Mortality. Cancer Research, 84(24), 1359.
[2] Reeder-Hayes, K., Jackson, B.E., & Kuo, T.M. (2024). Structural Racism and Treatment Delay Among Black and White Patients With Breast Cancer. Journal of Clinical Oncology, 42(14), 2483.
[3] Janevic, T., Howell, F.M., & Burdick, M. (2025). Racism and Postpartum Blood Pressure in a Multiethnic Prospective Cohort. Hypertension, 82(4), 23772.
[4] Sangaramoorthy, M., Lin, K., & Zhou, Y. (2025). Structural Racism and Lung Cancer Risk: The Multiethnic Cohort Study and Southern Community Cohort Study. Cancer Epidemiology, Biomarkers & Prevention, 34(Suppl), A146.
[5] Shariff-Marco, S., Guan, A., & Lin, K. (2025). The Development of Racial and Ethnic-Specific Composite Measures of Structural Racism for Cancer Inequities Research. Cancer Epidemiology, Biomarkers & Prevention, 34(Suppl), A109.